Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Measurement of Pyridine Nucleotides in Biological Samples Using LC-MS/MS.

Petucci C, Culver JA, Kapoor N, Sessions EH, Divlianska D, Gardell SJ.

Methods Mol Biol. 2019;1996:61-73. doi: 10.1007/978-1-4939-9488-5_7.

PMID:
31127548
2.

Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells.

Feng Y, Sessions EH, Zhang F, Ban F, Placencio-Hickok V, Ma CT, Zeng FY, Pass I, Terry DB, Cadwell G, Bankston LA, Liddington RC, Chung TDY, Pinkerton AB, Sergienko E, Gleave M, Bhowmick NA, Jackson MR, Cherkasov A, Ronai ZA.

Cancer Lett. 2019 May 1;449:145-162. doi: 10.1016/j.canlet.2019.02.012. Epub 2019 Feb 14.

PMID:
30771432
3.

Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme.

Lv Z, Yuan L, Atkison JH, Williams KM, Vega R, Sessions EH, Divlianska DB, Davies C, Chen Y, Olsen SK.

Nat Commun. 2018 Dec 4;9(1):5145. doi: 10.1038/s41467-018-07015-1.

4.

Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress.

Kirby RJ, Divlianska DB, Whig K, Bryan N, Morfa CJ, Koo A, Nguyen KH, Maloney P, Peddibhotla S, Sessions EH, Hershberger PM, Smith LH, Malany S.

J Pharmacol Exp Ther. 2018 Jan;364(1):87-96. doi: 10.1124/jpet.117.243717. Epub 2017 Nov 3. Erratum in: J Pharmacol Exp Ther. 2018 Feb;364(2):179.

PMID:
29101218
5.

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

Lechtenberg BC, Mace PD, Sessions EH, Williamson R, Stalder R, Wallez Y, Roth GP, Riedl SJ, Pasquale EB.

ACS Med Chem Lett. 2017 Jun 12;8(7):726-731. doi: 10.1021/acsmedchemlett.7b00127. eCollection 2017 Jul 13.

6.

Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway.

Hershberger PM, Peddibhotla S, Sessions EH, Divlianska DB, Correa RG, Pinkerton AB, Reed JC, Roth GP.

Beilstein J Org Chem. 2013 May 8;9:900-7. doi: 10.3762/bjoc.9.103. Print 2013.

7.

Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-II).

Sessions EH, Chowdhury S, Yin Y, Pocas JR, Grant W, Schröter T, Lin L, Ruiz C, Cameron MD, LoGrasso P, Bannister TD, Feng Y.

Bioorg Med Chem Lett. 2011 Dec 1;21(23):7113-8. doi: 10.1016/j.bmcl.2011.09.084. Epub 2011 Oct 1.

PMID:
22018789
8.

Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I).

Chowdhury S, Sessions EH, Pocas JR, Grant W, Schröter T, Lin L, Ruiz C, Cameron MD, Schürer S, LoGrasso P, Bannister TD, Feng Y.

Bioorg Med Chem Lett. 2011 Dec 1;21(23):7107-12. doi: 10.1016/j.bmcl.2011.09.083. Epub 2011 Sep 24.

PMID:
22004718
9.

Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation.

Khan PM, Correa RG, Divlianska DB, Peddibhotla S, Sessions EH, Magnuson G, Brown B, Suyama E, Yuan H, Mangravita-Novo A, Vicchiarelli M, Su Y, Vasile S, Smith LH, Diaz PW, Reed JC, Roth GP.

ACS Med Chem Lett. 2011 Oct 13;2(10):780-785. Epub 2011 Aug 5.

10.

Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors.

Fang X, Chen YT, Sessions EH, Chowdhury S, Vojkovsky T, Yin Y, Pocas JR, Grant W, Schröter T, Lin L, Ruiz C, Cameron MD, LoGrasso P, Bannister TD, Feng Y.

Bioorg Med Chem Lett. 2011 Mar 15;21(6):1844-8. doi: 10.1016/j.bmcl.2011.01.039. Epub 2011 Jan 14.

PMID:
21349713
11.

The development of benzimidazoles as selective rho kinase inhibitors.

Sessions EH, Smolinski M, Wang B, Frackowiak B, Chowdhury S, Yin Y, Chen YT, Ruiz C, Lin L, Pocas J, Schröter T, Cameron MD, LoGrasso P, Feng Y, Bannister TD.

Bioorg Med Chem Lett. 2010 Mar 15;20(6):1939-43. doi: 10.1016/j.bmcl.2010.01.124. Epub 2010 Feb 1.

PMID:
20167489
12.

Benzimidazole- and benzoxazole-based inhibitors of Rho kinase.

Sessions EH, Yin Y, Bannister TD, Weiser A, Griffin E, Pocas J, Cameron MD, Ruiz C, Lin L, Schürer SC, Schröter T, LoGrasso P, Feng Y.

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6390-3. doi: 10.1016/j.bmcl.2008.10.095. Epub 2008 Oct 25.

PMID:
18996009
13.

Furanosteroid studies. Stereoselective synthesis of the A,B,E-ring core of wortmannin.

Sessions EH, O'Connor RT Jr, Jacobi PA.

Org Lett. 2007 Aug 16;9(17):3221-4. Epub 2007 Jul 26.

PMID:
17655248
14.

Studies on the synthesis of furanosteroids. I. Viridin models.

Sessions EH, Jacobi PA.

Org Lett. 2006 Aug 31;8(18):4125-8.

PMID:
16928090
15.

Two-step electrochemical annulation for the assembly of polycyclic systems.

Whitehead CR, Sessions EH, Ghiviriga I, Wright DL.

Org Lett. 2002 Oct 17;4(21):3763-5.

PMID:
12375938
16.

Studies on inducers of nerve growth factor: synthesis of the cyathin core.

Wright DL, Whitehead CR, Sessions EH, Ghiviriga I, Frey DA.

Org Lett. 1999 Nov 18;1(10):1535-8.

PMID:
10836021

Supplemental Content

Loading ...
Support Center